>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
恶性胶质瘤术后同期推量调强放疗的疗效及其预后影响因素分析
作者:薛强 
单位:南通大学附属医院 放疗科, 江苏 南通 226000
关键词:胶质瘤 调强放疗 同期推量 预后 
分类号:R739.41
出版年·卷·期(页码):2016·35·第五期(746-751)
摘要:

目的:回顾性分析恶性胶质瘤术后行同期推量调强放疗(simultaneous integrated boost intensity-modulated radiotherapy,SIB-IMRT)的疗效及其预后影响因素。方法:2009年4月至2012年4月共94例恶性胶质瘤患者术后接受SIB-IMRT,行CT扫描定位,确定靶体积(GTV、CTV)和重要器官,GTV定义为部分切除或者次全切除后的残留病灶,而CTV则定义为包括术前肿瘤病灶在内的并往外扩2.0 cm边缘的范围。采用同期推量技术,设置处方剂量GTV为60 Gy,每次分割2.4 Gy,CTV为50 Gy,每次分割2 Gy,使用MIMIC系统实施调强放疗。记录放疗期间不良反应,并计算总体生存率。应用COX回归模型进行预后相关因素的多因素分析。结果:本组患者无4级以上急性不良反应,多为1~2级,有2例发生后期放射性脑坏死。患者的1、2和3年总生存率分别为81.1%、57.1%和30.7%,1、2和3年无局部进展生存率分别为65.3%、40.0%、11.8%。多因素分析显示影响总体生存率的独立预后因素包括肿瘤是否位于功能区(P=0.033、0.021)、病理分级(P=0.019、0.016)、肿瘤手术切除程度(P<0.001)。结论:采用术后同期推量调强放疗方法治疗恶性胶质瘤能够获得较为理想的近期临床疗效,而且患者对放疗相关的不良反应尚可耐受。肿瘤是否位于功能区、病理分级、肿瘤手术切除程度是重要的预后因素。

Objective: To evaluate the outcome and prognostic factors of simultaneous integrated boost intensity-modulated radiotherapy(SIB-IMRT)in the treatment of malignant gliomas. Methods: From Apr.2009 to Apr.2012, 94 cases of malignant glioma were treated with SIB-IMRT. All patients fixed with mask and had a CT scan. The target volumes(CTV,CTV)and organs at risk(OAR)were contoured. GTV was identified as residual focus after partial or near total resection, CTV as the preoperation focus with 2.0 cm margin. The doses of prescription were GTV 60 Gy, 2.4 Gy·f-1, CTV 50 Gy, 2.0 Gy·f-1 using SIB technique and IMRT was implemented with MIMIC system. The treatment reaction was recorded. The overall survival rate was calculated. The prognostic factors were analyzed by using multivariate COX regression model. Results: The acute treatment toxicity occurred mostly in grade 1 to grade 2 and no adverse reaction was observed in grade 4. Two cases had late radiation induced brain necrosis. The overall 1-, 2-, and 3-year survival rates were 81.1%, 57.1% and 30.7%, and the 1-year, 2-yera, and 3-year local progression free survival rate were 65.3%, 40.0% and 11.8%. Multivariate analysis revealed that tumor location, pathological grading and extent of resection were independent prognostic factors. Conclusion: Postoperative SIB-IMRT has a better short-term efficacy in the treatment of malignant glioma and the adverse reaction is tolerable. Tumor location, pathological grading and extent of resection are important prognostic factors.

参考文献:

[1] 《中国中枢神经系统胶质瘤诊断和治疗指南》编写组.中国中枢神经系统胶质瘤诊断和治疗指南(2012)[J].中华医学杂志,2013,93(31):2418-2449.
[2] 高翔.颅脑肿瘤治疗趋势[J].现代实用医学,2012,24(10):1084-1087.
[3] CHEN A M,FARWELL D G,LUU Q,et al.Intensity-modulated radiothera-PY is associated with improved global quality of life among long-term survivors of head and-neck cancer[J].Int J Radiat Oncol Biol Phys,2012,84(1):170-175.
[4] CHO K H,KIM P I T,LEE S H,et al.Simultaneous integrated boost intensity- modulated radiotherapy in patients with high-grade gliomas[J].Int J Radiat Oncol Biol Phys,2010,78(2):390-397.
[5] 殷蔚伯,谷铣之,陈东福.肿瘤放射治疗学[M].北京:中国协和医科大学出版社,2002:1109-1110.
[6] CAO J Q,FISHER B J,BAUMAN G S,et al.Hypofractionated radiotherapy with or without concurrent temozolomide in elderly patients with glioblastoma multiforme:a review of ten-year single institutional experience[J].J Neurooncol,2012,107(2):395-405.
[7] 蒋静,房彤,陈怡东,等.影响脑干胶质瘤放射治疗预后的相关因素分析[J].中华神经外科杂志,2013,29(11):1093-1096.
[8] PANET-RAYMOND V,SOUHAMI L,ROBERGE D,et al.Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme:a safety and efficacy analysis[J].Int J Radiat Oncot Biol Phys,2009,73(2):473-478.
[9] 何少忠,孙新臣,肖震宇,等.高分级脑胶质瘤同步加量调强放射治疗的疗效与剂量分析[J].中国临床研究,2013,26(9):900-902.
[10] 段伟,刘宁宁,高娜,等.老年食管癌三维适形放疗与调强放疗同步奈达铂化疗疗效观察[J].现代医学,2105,43(2):187-190.
[11] MCCREA H J,BANDER E D,VENN R A,et al.Sex,age,anatomic location,and extent of resection influence outcomes in children with high-grade glioma[J].Neurosurgery,2015,77(3):443-452.
[12] LOMBARDI G,PACE A,PASQULETTI F,et al.Predictors of survival and effect of short(40 Gy)or standard-course(60 Gy)irradiation plus concomitant temozolomide in elderly patients with glioblastoma:a multicenter retrospective study of AINO(Italian Association of Neuro-Oncology)[J].Neurosurgery,2015,125(2):359-367.
[13] 汪洋,盛晓芳,高晶,等.高分级神经胶质瘤112例术后放、化疗疗效及其预后分析[J].肿瘤,2009,29(7):668-672.
[14] 林清,金冶宁,吴国华,等.恶性脑胶质瘤的化疗以及与放疗的相互作用[J].中国肿瘤临床与康复,2007,14(6):560-562.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 405567 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364